Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.001 Å; R factor = 0.043; wR factor = 0.125; data-to-parameter ratio = 27.0. organic compounds o628 Fun et al.
In the title compound, C 12 H 14 N 2 O, the imidazole ring forms a dihedral angle of 66.73 (5) with the phenyl ring. In the crystal, molecules are linked via O-HÁ Á ÁN and C-HÁ Á ÁO hydrogen bonds into sheets lying parallel to (100). The crystal structure is further consolidated by C-HÁ Á Á interactions.
Related literature
For general background to and the pharmacological activities of the title compound, see: Latge (1999) ; Steenbergn & Casadevall (2000) ; Pacetti & Gelone (2003) ; Spellberg et al. (2006) . For the preparation of the title compound, see: Aboul-Enein et al. (2011) . For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986 Table 1 Hydrogen-bond geometry (Å , ).
Cg1 is the centroid of the C1-C6 phenyl ring. Symmetry codes: (i) Àx þ 1; y À 1 2 ; Àz þ 1 2 ; (ii) Àx þ 1; Ày; Àz þ 1; (iii) Àx þ 1; y þ 1 2 ; Àz þ 1 2 ; (iv) Àx; y þ 1 2 ; Àz þ 1 2 .
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008) ; program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 
Rashood Comment
Over the past three decades, the incidence of both community-acquired and nosocomial invasive fungal infections has increased substantially. Clinically, candidosis, aspergillosis and cryptococcosis have been identified as three major opportunistic pathogens in the etiology of fungal infections in immune compromised patients (Latge, 1999; Steenbergn & Casadevall, 2000) . Candida albicans accounts for the majority of invasive and superficial Candida infections (Pacetti & Gelone, 2003; Spellberg et al., 2006) . Accordingly, the need for new antifungal drugs has prompted intensive research worldwide. The azole antifungal drugs constitute one of the major classes which are characterized by having the azole pharmacophoric moiety embedded in their structures. The title molecule exhibited anti-Candida activity (MIC = 10 µg/ml) and can serve as a prototypic molecule for subsequent molecular modifications.
In the title compound, Fig. 1 , the imidazole ring (N1/N2/C10-C12, maximum deviation of 0.002 (1) Å at atoms N1 and C12) forms a dihedral angle of 66.73 (5)° with the phenyl ring (C1-C6).
In the crystal structure, Fig. 2 , molecules are linked via intermolecular O1-H1O1···N2 and C1-H1B···O1 hydrogen bonds (Table 1) into two-dimensional networks parallel to (100). The crystal structure is further consolidated by C10-H10A···Cg1 iii and C12-H12A···Cg1 iv (Table 1) interactions, where Cg1 is the centroid of C1-C6 phenyl ring.
Experimental
NaBH 4 (4.9 g, 0.13 mol) was added portion-wise to an ice cooled, stirred solution of 3-(1H-imidazol-1-yl)-1-phenylpropan-1-one (8.6 g, 0.043 mol) (Aboul-Enein et al., 2011) in methanol (100 ml). The mixture was stirred overnight at ambient temperature followed by evaporation of methanol under vacuum. The residue was dissolved in ethyl acetate (150 ml) and washed with water (3 × 50 ml). The organic layer was separated, dried (Na 2 SO 4 ) and evaporated under reduced pressure. The residue was recrystallized from ethanol to give the title compound as colourless blocks. M.p. = 380-382 K.
Refinement
Atom H1O1 was located in a difference Fourier map and refined freely with O1-H1O1 = 0.97 (2) Å. The remaining H atoms were positioned geometrically and refined using a riding model with C-H = 0.95 or 0.99 Å and U iso (H) = 1.2U eq (C).
Computing details
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009 ); data reduction: SAINT (Bruker, 2009 ); program(s) used to solve structure: SHELXTL (Sheldrick, 2008) ; program(s) used to refine structure: SHELXTL (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication:
SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009 The molecular structure of the title compound showing 50% probability displacement ellipsoids for non-H atoms.
Figure 2
The crystal structure of the title compound, viewed along the c axis. H atoms not involved in hydrogen bonds (dashed lines) have been omitted for clarity. (Cosier & Glazer, 1986) operating at 100.0 (1) K. Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > 2sigma(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
3-(1H-Imidazol-1-yl)-1-phenylpropan-1-ol

Crystal data
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) Symmetry codes: (i) −x+1, y−1/2, −z+1/2; (ii) −x+1, −y, −z+1; (iii) −x+1, y+1/2, −z+1/2; (iv) −x, y+1/2, −z+1/2.
